Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Phenomix Sciences
AddedFeb 16, 2024
UpdatedJun 28, 2026
Phenomix Sciences

Phenomix Sciences

Pre-Seed

Phenomix Sciences: A biotech firm excelling in life science, metabolomics, and genomics.

HQ
Rochester, MN, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Phenomix Sciences, founded with a mission to revolutionize obesity treatment through precision medicine, focuses on leveraging metabolomics and genomics to predict patient responses to various weight loss interventions. The company offers data-driven solutions that utilize biological samples and patient assessments analyzed by machine learning algorithms to provide personalized obesity phenotyping. Their primary market includes healthcare professionals and patients seeking tailored obesity management strategies.

Notable figures affiliated with Phenomix Sciences include experts in biotechnology and life sciences, although specific names are not provided. The company has achieved significant milestones in developing a comprehensive obesity phenotyping test, contributing to more effective and personalized treatment plans. Their impact lies in enhancing the precision of obesity treatments, potentially improving patient outcomes and advancing the field of metabolic health.

Phenomix Sciences - Quick Facts

When was Phenomix Sciences founded?

Phenomix Sciences was founded in 2017.

Where is Phenomix Sciences' headquarters located?

Phenomix Sciences' headquarters is located in Rochester, MN, US.

When was Phenomix Sciences' last funding round?

Phenomix Sciences' most recent funding round was for $1M (USD) in February 2023.

How much has Phenomix Sciences raised to-date?

As of Feb 22, 2023, Phenomix Sciences has raised a total of $3.2M (USD).

How many employees does Phenomix Sciences have?

Phenomix Sciences has 5 employees as of Feb 5, 2024.

Phenomix Sciences - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Main Product
  • Biotech
Tags
  • Biotech
  • Healthcare Professionals
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified